PTN

Palatin Tech

• TipRanks·03/20 13:30

  Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)

• Benzinga·03/20 12:05

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• TipRanks·02/18 14:00

  Palatin Technologies’ Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN)

• TipRanks·02/18 12:30

  Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Medline, Inc. Class A (MDLN) and Palatin Technologies (PTN)

• TipRanks·02/18 00:13

  Palatin Earnings Call: Cash Rebuilt, Obesity Bets Rising

• Seeking Alpha·02/17 12:43

  Palatin Technologies GAAP EPS of -$2.86 misses by $0.51, revenue of $0.11M beats by $0.09M

• Benzinga·02/17 12:35

  Palatin Techs Q2 EPS $(2.86) Misses $(2.69) Estimate, Sales $116.036K Beat $50.000K Estimate

• Dow Jones·02/17 12:31

  *Palatin Technologies 2Q Rev $116,036 >PTN

• Dow Jones·02/17 12:30

  Press Release: Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

• Dow Jones·02/17 12:30

  Press Release: Palatin Reports Second Quarter -2-

• Dow Jones·02/17 12:30

  Press Release: Palatin Reports Second Quarter -3-

• Dow Jones·02/17 12:30

  *Palatin Technologies 2Q Loss/Shr $2.86 >PTN

• TipRanks·12/17/2025 16:25

  Palatin Technologies Inc trading resumes

• TipRanks·12/17/2025 16:20

  Palatin Technologies Inc trading halted, volatility trading pause

• Dow Jones·12/12/2025 14:48

  Palatin Techs Price Target Announced at $60.00/Share by Laidlaw & Co.